Beta interferon and progression
18 July 2012
A Canadian study looked at time from eligibility for treatment to EDSS 6 in 868 people treated with interferon, 829 contemporaries who didn't have treatment and a group of 959 people whose MS had been studied before beta interferon was available. There was no significant difference between time to EDSS 6 between the treatment and non treatment groups. There was also no difference in the time to EDSS 4.
Items in Research News link to recent stories that may be of interest to people in the UK.
The MS Trust has not written the original items.
Click on the link beneath the item to be taken to the original story.